Hematology and Oncology
Home Hematology and Oncology
Some Aspects of Empathy Improve During Medical Training
Decrease in empathy as assessed by JSPE, but overall cognitive empathy improved on the QCAE
Antibiotic Rx Adherence Varies Widely in Sickle Cell Care
Guideline-adherent therapy tied to fewer 30-day readmissions
Most Opioid Use Concentrated in Top 10 Percent of Users
Top 10 percent of users accounted for 76 percent of the total annual morphine equivalents
Adjuvant Nivolumab Tops Ipilimumab in Melanoma
Longer recurrence-free survival for stage IIIB, IIIC, IV melanoma
Are Physicians Obligated to Help on Planes?
One administrative physician explains his sense of obligation to help
Dabrafenib, Trametinib Beneficial in Resected Melanoma
Rate of relapse-free survival up for resected stage III melanoma with BRAF V600E, V600K mutations
Longer Progression-Free Survival for Durvalumab in NSCLC
Longer median progression-free survival from randomization, higher response rate with durvalumab
Median Cost of Cancer Drug Development $648.0 Million
Total revenue from sales of 10 drugs was $67.0 billion, with total R&D spending of $7.2 billion
Zika Virus Preferentially Targets Glioblastoma Stem Cells
ZIKV preferentially infects, kills GSCs relative to differentiated tumor progeny, normal neuronal cells
Diverse Neurological Effects Linked to Anti-PD-1 Therapy
Complications seen after median of 5.5 cycles of anti-PD-1-inhibitors; include myopathy, neuropathies
